Kolinpharma S.p.A.

Informe acción BIT:KIP

Capitalización de mercado: €15.9m

Kolinpharma Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Rita Petrelli

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva3.8yrs

Actualizaciones recientes de la dirección

Recent updates

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

Jun 17
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Dec 01
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

Aug 25
An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Jun 08
We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

May 21
Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

May 03
Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

Apr 13
Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Feb 20
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Dec 28
Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Nov 22
These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

CEO

Rita Petrelli

no data

Permanencia

Dr. Rita Paola Petrelli is the Co-Founder, Chairwoman of The Board, Chief Executive Officer and Chief Financial Officer of Kolinpharma S.p.A. Dr. Petrelli is chartered accountant, auditor and technical-leg...


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Rita Petrelli
Co-Founderno datasin datossin datos
Massimo Mantella
CEO & Director4.4yrssin datossin datos
Francesco Spano
Independent Directorno datasin datossin datos
Pierluigi Pipolo
Chairman of the Board of Statutory Auditors3.8yrssin datossin datos
Giannunzio Corazza
Non-Executive Directorno datasin datossin datos
Edoardo Ferragina
Non-Executive Directorno datasin datossin datos
Maurizio Altini
Independent Directorno datasin datossin datos
Giulio Centemero
Standing Auditor3.8yrssin datossin datos
Roberto Giannella
Standing Auditor3.8yrssin datossin datos

3.8yrs

Permanencia media

Junta con experiencia: La junta directiva de KIP se considera experimentada (3.8 años de antigüedad promedio).